- Home
- CFBK vs KRRO Comparison
CFBK vs KRRO Comparison
Compare CFBK & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFBK
- KRRO
- Stock Information
- Founded
- CFBK 1892
- KRRO 2014
- Country
- CFBK United States
- KRRO United States
- Employees
- CFBK N/A
- KRRO N/A
- Industry
- CFBK Major Banks
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- CFBK Finance
- KRRO Health Care
- Exchange
- CFBK Nasdaq
- KRRO Nasdaq
- Market Cap
- CFBK 154.9M
- KRRO 125.4M
- IPO Year
- CFBK 1998
- KRRO 2019
- Fundamental
- Price
- CFBK $23.81
- KRRO $16.01
- Analyst Decision
- CFBK Buy
- KRRO Strong Buy
- Analyst Count
- CFBK 1
- KRRO 7
- Target Price
- CFBK $29.00
- KRRO $85.67
- AVG Volume (30 Days)
- CFBK 43.9K
- KRRO 129.9K
- Earning Date
- CFBK 08-04-2025
- KRRO 08-12-2025
- Dividend Yield
- CFBK 1.34%
- KRRO N/A
- EPS Growth
- CFBK N/A
- KRRO N/A
- EPS
- CFBK 2.28
- KRRO N/A
- Revenue
- CFBK $47,663,000.00
- KRRO $4,821,000.00
- Revenue This Year
- CFBK $35.39
- KRRO $65.08
- Revenue Next Year
- CFBK $10.11
- KRRO N/A
- P/E Ratio
- CFBK $10.43
- KRRO N/A
- Revenue Growth
- CFBK 1.22
- KRRO N/A
- 52 Week Low
- CFBK $19.23
- KRRO $10.29
- 52 Week High
- CFBK $31.17
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- CFBK 47.44
- KRRO 61.15
- Support Level
- CFBK $23.76
- KRRO $12.76
- Resistance Level
- CFBK $24.17
- KRRO $17.82
- Average True Range (ATR)
- CFBK 0.36
- KRRO 1.45
- MACD
- CFBK -0.03
- KRRO 0.38
- Stochastic Oscillator
- CFBK 30.30
- KRRO 65.89
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.